BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30585767)

  • 1. Adenovirus-Mediated CRM197 Sensitizes Human Glioma Cells to Gemcitabine by the Mitochondrial Pathway.
    Dai LX; Yang J; Liu JM; Huang S; Wang BN; Li H; Yang J; Zhao ZY; Cao K; Li MY
    Cancer Biother Radiopharm; 2019 Apr; 34(3):171-180. PubMed ID: 30585767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Plays a Key Role in the Apoptosis of Human Ovarian Cancer Cells Induced by Adenovirus-Mediated CRM197.
    Dai L; Pan Q; Peng Y; Huang S; Liu J; Chen T; Wang X; Chen D; Wang J; Zhu Y; Wang H; Liu Y; Ou Y; Yu X; Cao K
    Hum Gene Ther; 2018 Aug; 29(8):916-926. PubMed ID: 29620944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cellular growth, apoptosis, and Akt activity in human U251 glioma cells by a combination of cisplatin with CRM197.
    Wang L; Wang P; Liu Y; Xue Y
    Anticancer Drugs; 2012 Jan; 23(1):81-9. PubMed ID: 21934602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.
    Leitner S; Sweeney K; Oberg D; Davies D; Miranda E; Lemoine NR; Halldén G
    Clin Cancer Res; 2009 Mar; 15(5):1730-40. PubMed ID: 19223497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas.
    Szatmári T; Huszty G; Désaknai S; Spasokoukotskaja T; Sasvári-Székely M; Staub M; Esik O; Sáfrány G; Lumniczky K
    Cancer Gene Ther; 2008 Mar; 15(3):154-64. PubMed ID: 18188186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells.
    Hu Y; Lin X; Wang P; Xue YX; Li Z; Liu LB; Yu B; Feng TD; Liu YH
    J Cell Physiol; 2015 Aug; 230(8):1713-28. PubMed ID: 25201410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells.
    Mao L; Yang C; Li L; Nai L; Fan L; Wang J; Li W; Wen R; Chen J; Zheng J
    Tumour Biol; 2014 Jun; 35(6):5937-44. PubMed ID: 24604329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer.
    Dateoka S; Ohnishi Y; Kakudo K
    Med Mol Morphol; 2012 Jun; 45(2):91-7. PubMed ID: 22718294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.
    Han Z; Lee S; Je S; Eom CY; Choi HJ; Song JJ; Kim JH
    Apoptosis; 2016 Mar; 21(3):351-64. PubMed ID: 26677013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
    Fujiwara Y; Shiba H; Iwase R; Haruki K; Furukawa K; Uwagawa T; Misawa T; Ohashi T; Yanaga K
    J Am Coll Surg; 2013 Feb; 216(2):320-32.e3. PubMed ID: 23219147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
    Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
    J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine.
    Wu Y; Yang L; Hu B; Liu JY; Su JM; Luo Y; Ding ZY; Niu T; Li Q; Xie XJ; Wen YJ; Tian L; Kan B; Mao YQ; Wei YQ
    Anticancer Drugs; 2005 Jun; 16(5):551-7. PubMed ID: 15846121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
    Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
    Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
    Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
    Maliandi MV; Mato-Berciano A; Sobrevals L; Roué G; José A; Fillat C
    Mol Cancer; 2015 Jul; 14():146. PubMed ID: 26227809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.
    Réjiba S; Bigand C; Parmentier C; Hajri A
    Neoplasia; 2009 Jul; 11(7):637-50. PubMed ID: 19568409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.